10 results
An Algorithm for the Management of COVID-19 Hypoxic Respiratory Failure 

#algorithm #management #ddxof #sarscov2 #covid19 #Respiratory
An Algorithm for ... Management of COVID ... -19 Hypoxic Respiratory ... management #ddxof #sarscov2 ... #covid19 #Respiratory
Graded Oxygen Administration in COVID-19

#respiratory #support #COVID19 #management #schema #criticalcare #hypoxia #failure #algorithm #coronavirus #sarscov2 #oxygen
Administration in COVID ... -19 #respiratory ... #support #COVID19 ... hypoxia #failure #algorithm ... #coronavirus #sarscov2
COVID-19 RESPIRATORY PATHWAY ALGORITHM
Awake proning may help with oxygenation
Permissive hypoxemia, if closely monitored and in the
COVID-19 RESPIRATORY ... PATHWAY ALGORITHM ... FOAMpodcast #COVID19 ... #ALGORITHM #NIV ... #Coronavirus #SARSCOV2
Simplified Representation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Lifecycle and Potential Drug Targets

#Therapeutic
of Severe Acute Respiratory ... Syndrome Coronavirus ... Therapeutic #Targets #Pharmacology ... #SARSCOV2 #Coronavirus ... #COVID19 #JAMA
Triage Algorithm COVID-19

First draft of a PROPOSED pathway for identify 'happy hypoxic' #COVID19 patients at triage,
Triage Algorithm ... COVID-19 First ... cliffreid #Triage #Algorithm ... #Respiratory #Support ... #Management #SARSCOV2
Respiratory Support Algorithm for COVID-19 - Self-Proning

#Respiratory #Support #Algorithm #COVID19 #SelfProning #SARSCOV2
Respiratory Support ... Algorithm for COVID ... #Support #Algorithm ... #COVID19 #SelfProning ... #SARSCOV2
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... Cytokine Activation Syndrome ... correlate with severe COVID ... 20% - Upper respiratory ... #Pharmacology #
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
UCSF COVID-19 Adult ... Myalgias 10-50% • Respiratory ... Jen Babik, UCSF COVID ... Guide #Diagnosis #Algorithm ... #Protocol #SARSCoV2
Remdesivir (GS-5734) - manufactured by Gilead Sciences
Remdesivir blocks the replication of viruses by inserting into the
#Remdesivir #Pharmacology ... #Pathophysiology ... #COVID19 #SARSCOV2
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Guillain-Barre Pathophysiology ... like illnesses, COVID ... extremity, facial, respiratory ... patients) • Respiratory